Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
Read more at CNBC
-
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Business - MarketWatch - 4 hours ago -
Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales
Business - Financial Times - 11 hours ago -
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
Business - CNBC - October 15 -
Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
Top stories - NBC News - October 16
More from CNBC
-
Meta’s Reality Labs posts $4.4 billion loss in third quarter
Business - CNBC - 2 hours ago -
Microsoft dips on weak guidance after beating on earnings
Business - CNBC - 23 minutes ago -
Starbucks CEO pledges to fundamentally change strategy as sales fall for third straight quarter
Business - CNBC - 52 minutes ago -
Elon Musk ordered to attend $1 million voter lottery suit hearing in Philadelphia court
Business - CNBC - 9 minutes ago -
Coinbase shares fall as muted crypto trading leads to a third-quarter miss
Business - CNBC - 52 minutes ago
Latest in Business
-
‘I became very frugal’: My husband and I are 40. I have $200,000 in student debt, while he has $600,000 in retirement savings. Are we in trouble?
Business - MarketWatch - 6 minutes ago -
Elon Musk ordered to attend $1 million voter lottery suit hearing in Philadelphia court
Business - CNBC - 9 minutes ago -
‘Am I a monster for keeping this to myself?’ I bought a house with my boyfriend, but didn’t reveal I have $50,000 in investments. Do I come clean?
Business - MarketWatch - 13 minutes ago -
‘It was obvious I wasn’t in Kansas anymore’: My local bank has no cashiers — and it went downhill from there. What’s happened to all the banks?
Business - MarketWatch - 13 minutes ago -
Starbucks turns to Sharpies and a price freeze to stem traffic slide
Business - Financial Times - 16 minutes ago